Harmony Biosciences Holdings, Inc. (HRMY)

Last Closing Price: 28.93 (2024-04-25)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Harmony Biosciences Holdings, Inc. (HRMY) had Net Income of $26.61M for the most recently reported fiscal quarter, ending 2023-12-31.

Figures for fiscal quarter ending 2023-12-31
Income Statement Financials
$168.41M
Net Income
$26.61M
$43.15M
$125.26M
$128.22M
$40.20M
$-0.51M
$39.69M
$39.69M
$26.61M
$26.61M
$26.61M
$26.61M
$40.20M
$45.82M
59.47M
60.37M
$0.47
$0.46
Balance Sheet Financials
$451.07M
$0.37M
$360.38M
$811.45M
$163.78M
$178.57M
$180.68M
$344.46M
$466.99M
$329.88M
$466.99M
56.77M
Cash Flow Statement Financials
$219.39M
$-46.44M
$-105.55M
$244.53M
$311.93M
$67.40M
$31.70M
--
--
Fundamental Metrics & Ratios
2.75
--
--
0.28
0.41
74.38%
23.87%
23.87%
--
23.57%
15.80%
$219.07M
--
--
--
0.21
8.05
2.27
39.62
5.70%
8.07%
3.28%
4.12%
$8.23
$3.63
$3.63